secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001193125-26-051379
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud

Plus Therapeutics Approves FY2025 Cash Bonuses: CEO Hedrick Gets $305,663, CFO Sims Gets $149,175
--------------------------------------------------------------------------------

- On Feb 9, 2026, Compensation Committee approved discretionary cash bonuses for Named Executive Officers for FY2025.
- CEO Marc H. Hedrick received a $305,663 cash bonus; total 2025 compensation was $5,566,732.
- CFO Andrew Sims received a $149,175 cash bonus; total 2025 compensation was $1,631,279.
- Former CMO Norman LaFrance, who stepped down in June 2024, received $0 compensation in FY2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/0001193125-26-051379-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526051379/pstv-20260209.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-051379

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer